paediatrics Brussels 17

B. Timmermann et al. / Radiotherapy and Oncology 77 (2005) 278–285

285

[40] Rousseau P, Habrand JL, Sarrazin D, et al. Treatment of intracranial ependymomas of children: review of a 15-year experience. Int J Radiat Oncol Biol Phys 1994;28:381–6. [41] Shaw EG, Evans RG, Scheithauer BW, Ilstrup DM, Earle JD. Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys 1987; 13:1457–62. [42] Silber JH, Radcliffe J, Peckham V, et al. Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score. J Clin Oncol 1992;10:1390–6. [43] Suc E, Kalifa C, Brauner R, et al. Brain tumours under the age of three. The price of survival. A retrospective study of 20 long- term survivors. Acta Neurochir (Wien) 1990;106:93–8. [44] Timmermann B, Kortmann RD, Kuhl J, et al. Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys 2000; 46:287–95. [45] Tomita T, McLone DG. Brain tumors during the first twenty-four months of life. Neurosurgery 1985;17:913–9. [46] van Eys J, Cangir A, Coody D, Smith B. MOPP regimen as primary chemotherapy for brain tumors in infants. J Neurooncol 1985;3: 237–43. [47] van Veelen-Vincent ML, Pierre-Kahn A, Kalifa C, et al. Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy. J Neurosurg 2002;97:827–35. [48] Wallner KE, Wara WM, Sheline GE, Davis RL. Intracranial ependymomas: results of treatment with partial or whole brain irradiation without spinal irradiation. Int J Radiat Oncol Biol Phys 1986;12:1937–41. [49] White L, Kellie S, Gray E, et al. Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. A Study of the Australian and New Zealand Children’s Cancer Study Group (ANZCCSG). J Pediatr Hematol Oncol 1998;20: 125–30.

[29] Merchant TE, Haida T, Wang MH, Finlay JL, Leibel SA. Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy. J Neurosurg 1997;86: 943–9. [30] Merchant TE, Mulhern RK, Krasin MJ, et al. Preliminary results froma phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 2004;22:3156–62. [31] Mork SJ, Loken AC. Ependymoma: a follow-up study of 101 cases. Cancer 1977;40:907–15. [32] Mulhern RK, Hancock J, Fairclough D, Kun L. Neuropsycholo- gical status of children treated for brain tumors: a critical review and integrative analysis. Med Pediatr Oncol 1992;20: 181–91. [33] Nazar GB, Hoffman HJ, Becker LE, Jenkin D, Humphreys RP, Hendrick EB. Infratentorial ependymomas in childhood: prog- nostic factors and treatment. J Neurosurg 1990;72:408–17. [34] Oya N, Shibamoto Y, Nagata Y, Negoro Y, Hiraoka M. Post- operative radiotherapy for intracranial ependymoma: analysis of prognostic factors and patterns of failure. J Neurooncol 2002;56:87–94. [35] Palma L, Celli P, Mariottini A, Zalaffi A, Schettini G. The importance of surgery in supratentorial ependymomas. Long- term survival in a series of 23 cases. Childs Nerv Syst 2000;16: 170–5. [36] Paulino AC, Wen BC, Buatti JM, et al. Intracranial ependymo- mas: an analysis of prognostic factors and patterns of failure. Am J Clin Oncol 2002;25:117–22. [37] Pollack IF. Brain tumors in children. N Engl J Med 1994;331: 1500–7. [38] Pollack IF, Gerszten PC, Martinez AJ, et al. Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 1995;37:655–66 [discussion 666–657]. [39] Robertson PL, Zeltzer PM, Boyett JM, et al. Survival and prognostic factors following radiation therapy and chemother- apy for ependymomas in children: a report of the Children’s Cancer Group. J Neurosurg 1998;88:695–703.